PureTech Health plc (LON:PRTC)
London · Delayed Price · Currency is GBP · Price in GBX 125.40
-0.60 (-0.48%)
May 6, 2026, 3:05 PM GMT
PureTech Health Employees
PureTech Health had 56 employees as of December 31, 2024. The number of employees decreased by 34 or -37.78% compared to the previous year.
Employees
56
Change (1Y)
-34
Growth (1Y)
-37.78%
Revenue / Employee
61.81K GBP
Profits / Employee
-1.46M GBP
Market Cap
306.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 56 | -34 | -37.78% |
| Dec 31, 2023 | 90 | -21 | -18.92% |
| Dec 31, 2022 | 111 | 16 | 16.84% |
| Dec 31, 2021 | 95 | -155 | -62.00% |
| Dec 31, 2020 | 250 | -50 | -16.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genus | 3,190 |
| Oxford Nanopore Technologies | 1,335 |
| Oxford Biomedica | 977 |
| hVIVO | 376 |
| Avacta Group | 151 |
| 4basebio | 110 |
| Scancell Holdings | 60 |
| Faron Pharmaceuticals Oy | 33 |
PureTech Health News
- 6 days ago - PureTech Health PLC (PTCHF) Full Year 2025 Earnings Call Highlights: Strategic Innovations and ... - GuruFocus
- 6 days ago - Full Year 2025 PureTech Health PLC Earnings Call Transcript - GuruFocus
- 7 days ago - PureTech Health Earnings Call Transcript: H2 2025 - Transcripts
- 7 days ago - PureTech Health (PRTC) to Delist from Nasdaq, Remaining Listed on London Stock Exchange - GuruFocus
- 7 days ago - PureTech Announces Annual Results for Year Ended December 31, 2025 - Business Wire
- 7 days ago - PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange - Business Wire
- 9 days ago - PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors - Business Wire
- 14 days ago - Positive Phase 1b Results for PureTech Health (PRTC) - GuruFocus